Hepcinate contains Sofosbuvir
Hepcinate Sovaldi (Sofosbuvir) is the first drug that has demonstrated safety and efficacy to treat certain types of HCV infection without the need for co-administration of interferon.
Hepcinate Sovaldi (Sofosbuvir) is a hepatitis C virus (HCV) nucleotide analog NS5B polymerase inhibitor, among the second generation of protease inhibitors that directly attack the Hep C virus cell.
Hepcinate is a Generic for the Sovaldi (Sofosbuvir) .
Hepcinate (Sofosbuvir) is very economical brand .
Hepcinate (Sofosbuvir) Has a same Quality as for the Original Brand of Hepcinate (Sofosbuvir)